ENTRY       D11892                      Drug
NAME        Imsidolimab (USAN)
FORMULA     C6516H10100N1732O2018S54
EXACT_MASS  146628.5865
MOL_WEIGHT  146719.8188
SEQUENCE    (Heavy chain)
            QVQLVQSGAE VKKPGASVKV SCKASGYTFT NYWMNWVRQA PRQGLEWMGM FHPTGDVTRL
            NQKFKDRVTM TRDTSTSTVY MELSSLRSED TAVYYCARTT SMIIGGFAYW GQGTLVTVSS
            ASTKGPSVFP LAPCSRSTSE STAALGCLVK DYFPEPVTVS WNSGALTSGV HTFPAVLQSS
            GLYSLSSVVT VPSSSLGTKT YTCNVDHKPS NTKVDKRVES KYGPPCPPCP APEFLGGPSV
            FLFPPKPKDT LMISRTPEVT CVVVDVSQED PEVQFNWYVD GVEVHNAKTK PREEQFNSTY
            RVVSVLTVLH QDWLNGKEYK CKVSNKGLPS SIEKTISKAK GQPREPQVYT LPPSQEEMTK
            NQVSLTCLVK GFYPSDIAVE WESNGQPENN YKTTPPVLDS DGSFFLYSRL TVDKSRWQEG
            NVFSCSVMHE ALHNHYTQKS LSLSLGK
            (Light chain)
            DIVMTQTPLS LSVTPGQPAS ISCRSSKSLL HRNAITYFYW YLHKPGQPPQ LLIYQMSNLA
            SGVPDRFSGS GSGTDFTLKI SRVEAEDVGV YYCAQNLELP LTFGGGTKVE IKRTVAAPSV
            FIFPPSDEQL KSGTASVVCL LNNFYPREAK VQWKVDNALQ SGNSQESVTE QDSKDSTYSL
            SSTLTLSKAD YEKHKVYACE VTHQGLSSPV TKSFNRGEC
            (Disulfide bridge: H22-H96, H134-L219, H147-H203, H226-H'226, H229-H'229, H261-H321, H367-H425, H'22-H'96, H'134-L'219, H'147-H'203, H'261-H'321, H'367-H'425, L23-L93, L139-L199, L'23-L'93, L'139-L'199)
  TYPE      Peptide
EFFICACY    Antipsoriatic, Anti-IL-36 receptor antagonist
  TYPE      Monoclonal antibody
COMMENT     Treatment of patients with generalized pustular psoriasis (GPP) and palmo-plantar pustular psoriasis (PPP)
TARGET      IL1RL2 (IL-36R) [HSA:8808] [KO:K05172]
  PATHWAY   hsa04060(8808)  Cytokine-cytokine receptor interaction
BRITE       Target-based classification of drugs [BR:br08310]
             Cytokines and receptors
              Cytokine receptors
               Interleukin receptors
                IL1RL2 (IL-36R)
                 D11892  Imsidolimab (USAN)
DBLINKS     CAS: 2102543-86-0
///
